558 related articles for article (PubMed ID: 11879884)
1. Blinding in randomised trials: hiding who got what.
Schulz KF; Grimes DA
Lancet; 2002 Feb; 359(9307):696-700. PubMed ID: 11879884
[TBL] [Abstract][Full Text] [Related]
2. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
Haahr MT; Hróbjartsson A
Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
[TBL] [Abstract][Full Text] [Related]
3. The blind leading the blind: use and misuse of blinding in randomized controlled trials.
Miller LE; Stewart ME
Contemp Clin Trials; 2011 Mar; 32(2):240-3. PubMed ID: 21070890
[TBL] [Abstract][Full Text] [Related]
4. Blinding in randomized clinical trials: imposed impartiality.
Hróbjartsson A; Boutron I
Clin Pharmacol Ther; 2011 Nov; 90(5):732-6. PubMed ID: 21993424
[TBL] [Abstract][Full Text] [Related]
5. An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods.
Devereaux PJ; Choi PT; El-Dika S; Bhandari M; Montori VM; Schünemann HJ; Garg AX; Busse JW; Heels-Ansdell D; Ghali WA; Manns BJ; Guyatt GH
J Clin Epidemiol; 2004 Dec; 57(12):1232-6. PubMed ID: 15617948
[TBL] [Abstract][Full Text] [Related]
6. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.
Fergusson D; Glass KC; Waring D; Shapiro S
BMJ; 2004 Feb; 328(7437):432. PubMed ID: 14761905
[TBL] [Abstract][Full Text] [Related]
7. Blinding terminology used in reports of randomized controlled trials involving dogs and cats.
Giuffrida MA; Agnello KA; Brown DC
J Am Vet Med Assoc; 2012 Nov; 241(9):1221-6. PubMed ID: 23078571
[TBL] [Abstract][Full Text] [Related]
8. Reporting of outcomes in orthopaedic randomized trials: does blinding of outcome assessors matter?
Poolman RW; Struijs PA; Krips R; Sierevelt IN; Marti RK; Farrokhyar F; Bhandari M
J Bone Joint Surg Am; 2007 Mar; 89(3):550-8. PubMed ID: 17332104
[TBL] [Abstract][Full Text] [Related]
9. Who knew? The misleading specificity of "double-blind" and what to do about it.
Lang TA; Stroup DF
Trials; 2020 Aug; 21(1):697. PubMed ID: 32758278
[TBL] [Abstract][Full Text] [Related]
10. In the dark: the reporting of blinding status in randomized controlled trials.
Montori VM; Bhandari M; Devereaux PJ; Manns BJ; Ghali WA; Guyatt GH
J Clin Epidemiol; 2002 Aug; 55(8):787-90. PubMed ID: 12384193
[TBL] [Abstract][Full Text] [Related]
11. Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials.
Boutron I; Tubach F; Giraudeau B; Ravaud P
J Clin Epidemiol; 2004 Jun; 57(6):543-50. PubMed ID: 15246122
[TBL] [Abstract][Full Text] [Related]
12. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials.
Devereaux PJ; Manns BJ; Ghali WA; Quan H; Lacchetti C; Montori VM; Bhandari M; Guyatt GH
JAMA; 2001 Apr; 285(15):2000-3. PubMed ID: 11308438
[TBL] [Abstract][Full Text] [Related]
13. Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study.
Moustgaard H; Clayton GL; Jones HE; Boutron I; Jørgensen L; Laursen DRT; Olsen MF; Paludan-Müller A; Ravaud P; Savović J; Sterne JAC; Higgins JPT; Hróbjartsson A
BMJ; 2020 Jan; 368():l6802. PubMed ID: 31964641
[TBL] [Abstract][Full Text] [Related]
14. Definitions of blinding in randomised controlled trials of interventions published in high-impact anaesthesiology journals: a methodological study and survey of authors.
Penić A; Begić D; Balajić K; Kowalski M; Marušić A; Puljak L
BMJ Open; 2020 Apr; 10(4):e035168. PubMed ID: 32284390
[TBL] [Abstract][Full Text] [Related]
15. Influence of blinding on treatment effect size estimate in randomized controlled trials of oral health interventions.
Saltaji H; Armijo-Olivo S; Cummings GG; Amin M; da Costa BR; Flores-Mir C
BMC Med Res Methodol; 2018 May; 18(1):42. PubMed ID: 29776394
[TBL] [Abstract][Full Text] [Related]
16. Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology.
Schulz KF; Grimes DA; Altman DG; Hayes RJ
BMJ; 1996 Mar; 312(7033):742-4. PubMed ID: 8605459
[TBL] [Abstract][Full Text] [Related]
17. Blinding in clinical trials: a practical approach.
Bang H; Park JJ
J Altern Complement Med; 2013 Apr; 19(4):367-9. PubMed ID: 23140113
[TBL] [Abstract][Full Text] [Related]
18. Placebo surgery research: a blinding imperative.
Heckerling PS
J Clin Epidemiol; 2006 Sep; 59(9):876-80. PubMed ID: 16895807
[TBL] [Abstract][Full Text] [Related]
19. Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid.
Akl EA; Sun X; Busse JW; Johnston BC; Briel M; Mulla S; You JJ; Bassler D; Lamontagne F; Vera C; Alshurafa M; Katsios CM; Heels-Ansdell D; Zhou Q; Mills E; Guyatt GH
J Clin Epidemiol; 2012 Mar; 65(3):262-7. PubMed ID: 22200346
[TBL] [Abstract][Full Text] [Related]
20. Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review.
Boutron I; Estellat C; Guittet L; Dechartres A; Sackett DL; Hróbjartsson A; Ravaud P
PLoS Med; 2006 Oct; 3(10):e425. PubMed ID: 17076559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
